Corbus Pharmaceuticals Holdings Inc. Stock Slides 19.9%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. tumbled 19.9% to $2.86 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 5.5% to 24,315.00 and Dow Jones Industrial Average falling 3.4% to 51,523.06.

This was the stock's fourth consecutive day of losses.

Corbus Pharmaceuticals Holdings Inc. closed 77.8% short of its 52-week high of $12.88, which the company achieved on May 22nd.

The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 7.5% to $3.59, Fortress Biotech Inc. fell 6.6% to $1.84, and Viking Therapeutics Inc. fell 7.79% to $25.79.

Trading volume totaled 1.4 million, compared to the 50-day average of 1.2 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

November 05, 2026 16:32 ET (21:32 GMT)